Companies: 10,795·Total market cap: $144.5T
Opus Genetics, Inc.

Opus Genetics, Inc.

IRDNASDAQHealthcare● Active
$4.03
+$0.00(+0.00%)
Market Cap$328024022
P/E Ratio
52W High$5.81
52W Low$0.9
Overview

Opus Genetics, Inc.(IRD)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · IRD · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$14.20M$10.99M$19.05M$39.85M$0.59M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$14.20M$10.99M$19.05M$39.85M$0.59M
Gross Margin %(computed)100.00%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$30.81M$26.85M$17.65M$14.36M$15.17M
G&A Expenses$21.98M$18.21M$11.96M$7.27M$8.12M
Total Operating Expenses$52.80M$73.07M$29.61M$21.62M$23.29M
Operating Income($38.60M)($62.07M)($10.56M)$18.23M($22.70M)
Operating Margin %(computed)-271.90%-564.72%-55.45%45.74%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$1.47M$0.00M$1.33M$0.01M$0.00M
Income Before Tax($49.59M)($57.53M)($9.97M)$18.20M($56.69M)
Income Tax Expense$0.00M$0.00M$0.01M$0.32M$0.00M
Net Income($49.59M)($57.53M)($9.99M)$17.89M($56.69M)
Net Margin %(computed)-349.33%-523.40%-52.42%44.89%
Per Share & EBITDA
EPS (Basic)$-0.80$-2.15$-0.46$0.90$-3.82
Wtd Avg Shares622.22M26.72M21.59M19.93M14.85M
EBITDA($48.07M)($57.52M)($9.97M)$18.22M($56.69M)
EBITDA Margin %(computed)-338.63%-523.31%-52.33%45.71%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Opus Genetics, Inc.

关于Opus Genetics, Inc.(IRD)损益表

Opus Genetics, Inc.(IRD)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,IRD实现营收$0.01B,毛利润$0.01B(毛利率100.00%),净利润($0.05B)(净利率-349.33%)。

常见问题

IRD · 4 问

Opus Genetics, Inc.(IRD)2025财年营收为$0.01B,同比up29.1%。

IRD revenueIRD salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08